Skip to content

Clinical trials

Completed Phase 2 Thromboembolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Phase: Phase 2 Status: Completed Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20031
20063
20073
20081
20091
20111
20121
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc4
Bayer1
Daiichi Sankyo1
Daiichi Sankyo Co., Ltd.1
GlaxoSmithKline1
Hull University Teaching Hospitals NHS Trust1
Landspitali University Hospital1
Masonic Cancer Center, University of Minnesota1
McMaster University1
Memorial Sloan Kettering Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism16
Atrial Fibrillation4
Venous Thromboembolism4
Stroke2
Venous Thrombosis2
Carcinoma, Ovarian Epithelial1
Embolism and Thrombosis1
Endometrial Neoplasms1
Fallopian Tube Neoplasms1
Head and Neck Neoplasms1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.